Recoverying from third and fourth degree burns, the most damaging types, is a slow and painful process that inevitably leaves excessive scar tissue. Russian researchers have developed a pharmacological enzyme preparation to accelerate the debridement process and wound healing, which reduces the preparation time for grafting and diminishes scarring.

Their product, called ENZYCOL, is a mixture of collagenases from the Kamchatka crab that rapidly dissolves the dense collagen matrix of necrot

New statistical research carried out by a team of experts at the University of Southampton suggests that the number of people dying as a result of diabetes may be directly influenced by ‘male macho attitudes’.

Professors Robert Peveler and Colin Pritchard of the Mental Health research unit at the University’s School of Medicine found that during the period studied (1974-1997) while the numbers of youth and young adults dying from diabetes fell, there was still a disproportionately higher de

Evolution Robotics ER Vision™ Software to be licensed by Entertainment Robot Company – ERC – a Division of Sony Corporation

Evolution Robotics™ Inc., a leading provider of state-of-the-art robotics solutions, today announced a technology licensing agreement with Entertainment Robot Company – ERC – a division of Sony Corporation (NYSE:SNE). Evolution Robotics will work closely with Sony ERC to optimize ER Vision™ for use in future Sony ERC products.

Sony chose to work with Ev

ESC Congress 2003

Aortic stenosis (AS) is the narrowing or obstruction of the heart´s aortic valve, which prevents it from opening properly and blocks the flow of blood from the left ventricle to the aorta. AS is common in the ageing population and has become the most frequent native valve disease in Europe. AS when severe, may cause left heart failure, fainting or angina, but the natural progression of less severe degrees is highly variable.

The risk factors for the developm

Surgical repair of such aneurysms and interposition of vascular protheses were until recently the only treatment option for complicated cases (diameter „d 5.5 cm; impending rupture; malperfusion syndrome; recurrent pain). Although great strides have been achieved by improving surgical techniques, postoperative complications (such as persistent paralysis of both legs, stroke, acute renal failure or pulmonary dysfunction) and 30-day mortality remain high. Especially elderly patients with accompanying

Are they really capable of replacing injured cells and reducing infarct size?

The new concept of cell transplantation has been addressed by two recent human investigations. Bone marrow cells of the patient are injected into the coronary circulation about one week after myocardial infarct to replace the injured cells and reduce the infarct size. This intervention seemed to be successful to reduce the contractile malefunction after myocardial infarction. The background of this observati